PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\'Aquila, L\'Aquila, Italy. piero.ruscitti@univaq.it.\', \'Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L\'Aquila, L\'Aquila, Italy.\', \'Rheumatology and Immunology Unit, Department of Medicine, University of Rome \'Campus Biomedico\', Rome, Italy.\', \'Rheumatology Unit, Department of Clinical Medicine and Surgery, School of Medicine, University of Naples Federico II, Naples, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s42358-021-00204-5
?:doi
?:hasPublicationType
?:journal
  • Advances in rheumatology (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34238376
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all